Complete Filing Data
Totaligent, Inc. reported Operating Income Loss of -$884.7 thousand for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Totaligent, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$947.2K | -$402.2K | -$592.1K | -$1.0M | -$866.7K | $262.8K | $257.6K | -$3.2M | |
| Cost of Revenue * | $401.5K | $481.3K | $46.9K | $3.4M | $3.1M | $3.0M | $2.6M | $625.7K | |
| Operating Income Loss | -$884.7K | -$354.0K | -$551.6K | -$511.6K | -$10.7K | -$952.7K | $126.1K | -$126.6K | -$2.4M |
| Operating Expenses | $927.7K | $604.3K | $524.2K | $511.6K | $10.7K | $3.7M | $2.2M | $1.7M | $2.4M |
| Revenues | $444.5K | $731.7K | $19.5K | $4.7M | $5.8M | $5.3M | $4.2M | $635.2K | |
| Gross Profit | $43.1K | $250.3K | -$27.4K | $1.3M | $2.8M | $2.3M | $1.5M | $9.5K | |
| General And Administrative Expense | $196.8K | $106.6K | $113.9K | $403.6K | $10.7K | $371.8K | $198.0K | $207.6K | |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $180.4K | $327.5K | $305.2K | $0.00 | $0.00 | |
| Nonoperating Income Expense | $761.4K | $714.8K | $441.9K | -$384.2K | -$717.0K | ||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$840.4K | -$237.9K | $568.0K | $257.6K | -$3.2M | ||||
| Research And Development Expense | $815.8K | $557.4K | $472.2K | $199.1K | $18.8K | ||||
| Research And Development Grant | $630.7K | $617.9K | $527.0K | -$302.9K | |||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.3M | $215.0K | -$826.7K | -$253.4K | |||||
| Deferred Income Tax Expense Benefit | $180.5K | $327.5K | $305.2K | ||||||
| Other Nonoperating Income Expense | -$62.6K | -$48.2K | -$40.5K | $182.6K | |||||
| Interest Expense | $47.2K | $35.1K | $30.6K | $4.6K | $7.8K | ||||
| Other Comprehensive Income Loss Net Of Tax | -$819.7K | $4.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$117.4K | -$54.8K | -$165.5K | -$575.4K | -$123.8K | -$140.5K | -$170.9K | -$49.8K | -$145.4K | -$1.8M | -$3.2M | -$147.3K | -$166.6K | -$677.3K | -$5.6K | -$258.3K | -$9.4K | -$3.0K | -$296.2K | -$139.6K | -$327.8K | -$327.6K | -$250.7K | -$313.1K | -$198.7K | $93.0K | $8.3K | -$87.3K | -$131.9K | -$230.3K | -$217.3K | $361.6K | -$226.2K |
| Cost of Revenue * | $0.00 | $0.00 | $0.00 | $30.9K | $37.5K | $328.6K | $60.0K | $9.9K | $62.8K | $40.0K | $949.9K | $839.2K | $933.3K | $814.5K | $675.2K | $816.8K | $689.2K | $723.5K | $774.2K | $19.6K | $787.9K | $770.8K | $880.00 | $0.00 | |||||||||
| Operating Income Loss | -$115.1K | -$104.5K | -$78.0K | -$458.5K | -$105.9K | -$154.8K | -$81.8K | -$78.4K | -$1.8M | -$3.2M | -$140.4K | -$147.7K | -$677.3K | -$5.6K | -$417.2K | -$6.1K | -$45.00 | -$480.0K | -$164.4K | -$502.2K | -$429.8K | -$134.5K | -$299.9K | -$250.9K | -$27.0K | -$18.9K | -$106.8K | -$110.2K | -$155.6K | -$176.8K | -$131.1K | -$111.7K | |
| Operating Expenses | $117.3K | $104.5K | $78.0K | $457.6K | $141.9K | $167.2K | $356.1K | $128.5K | $140.4K | $153.7K | $8.7K | $5.6K | $881.7K | $6.1K | $45.00 | $810.8K | $625.1K | $828.5K | $1.2M | $932.8K | $718.1K | $233.3K | $570.2K | $557.8K | $108.9K | $109.9K | $156.3K | $177.1K | $131.3K | $112.4K | |||
| Revenues | $2.2K | $0.00 | $0.00 | $30.0K | $73.6K | $340.9K | $334.2K | $60.0K | $56.1K | $54.5K | $1.2M | $1.3M | $1.2M | $1.1M | $1.1M | $1.1M | $1.4M | $1.5M | $1.2M | $2.0K | $1.3M | $1.3M | $2.1K | $494.00 | $643.00 | $283.00 | $126.00 | $624.00 | |||||
| Gross Profit | $2.2K | $0.00 | $0.00 | -$889.00 | $36.1K | $12.3K | $274.2K | $50.1K | -$6.8K | $14.5K | $240.2K | $464.4K | $316.3K | $330.8K | $460.7K | $326.4K | $759.8K | $798.3K | $418.2K | -$17.6K | $543.2K | $538.8K | $2.1K | -$386.00 | $643.00 | $283.00 | $126.00 | ||||||
| General And Administrative Expense | $28.2K | $74.5K | $72.5K | $55.6K | $47.3K | $61.2K | $30.1K | $34.0K | $30.8K | $153.7K | $8.7K | $5.6K | $90.9K | $6.1K | $45.00 | $153.5K | $83.9K | $127.0K | $121.4K | $226.4K | $126.0K | $128.8K | $62.3K | ||||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $16.3K | $57.8K | $18.5K | -$13.7K | $125.4K | $5.8K | $25.8K | $128.2K | $49.2K | $73.0K | $90.2K | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Nonoperating Income Expense | $199.0K | $216.7K | $188.9K | $170.2K | $150.2K | $180.2K | $131.8K | $138.4K | $207.1K | $52.2K | $193.0K | $117.4K | $19.5K | -$21.7K | -$74.7K | -$40.5K | $492.8K | -$114.4K | |||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$200.5K | -$621.8K | -$309.9K | -$14.2K | -$322.0K | -$298.0K | $3.9K | -$92.8K | -$198.7K | $166.0K | $98.5K | -$87.3K | -$131.9K | -$230.3K | -$217.3K | $361.6K | -$226.2K | ||||||||||||||||
| Research And Development Expense | $95.0K | $104.6K | $140.2K | $125.8K | $226.0K | $216.1K | $174.2K | $192.0K | $200.9K | $130.5K | $77.9K | $109.4K | $109.4K | $122.1K | $118.1K | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Research And Development Grant | $147.9K | $129.7K | $119.8K | $143.2K | $128.1K | $152.7K | $109.4K | $111.9K | $183.3K | $169.5K | $93.5K | ||||||||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $198.3K | $186.1K | -$430.5K | -$387.0K | -$403.9K | -$494.8K | $228.8K | -$297.6K | $141.3K | $24.6K | -$63.6K | ||||||||||||||||||||||
| Deferred Income Tax Expense Benefit | $16.3K | $57.8K | $18.5K | -$13.7K | $125.4K | $5.9K | $25.8K | $128.2K | $49.1K | $73.0K | |||||||||||||||||||||||
| Other Nonoperating Income Expense | -$2.4K | $49.7K | -$87.5K | -$116.9K | -$17.9K | $27.0K | -$89.0K | $28.6K | -$5.9K | $36.1K | -$5.7K | -$1.9K | |||||||||||||||||||||
| Interest Expense | $17.3K | $17.1K | $13.8K | $11.9K | $11.3K | $11.3K | $8.7K | $8.0K | -$2.6K | -$4.5K | $6.9K | -$18.9K | $330.00 | $3.3K | $3.0K | ||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax | -$98.7K | -$705.8K | $117.6K | -$55.3K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$761.1K | -$169.0K | $31.6K | -$91.8K | $7.7M | $7.9M | $8.0M | -$505.3K | |||
| Cash And Cash Equivalents At Carrying Value | $518.00 | $5.6M | $2.9M | $28.5K | |||||||
| Assets | $486.8K | $149.1K | $31.6K | $42.3M | $39.2M | $40.2M | $497.1K | ||||
| Liabilities | $1.4M | $910.1K | $35.7M | $31.6M | $32.2M | $2.6M | |||||
| Retained Earnings Accumulated Deficit | -$860.1K | -$458.0K | -$110.3K | -$7.6M | -$6.7M | -$6.9M | -$9.0M | ||||
| Liabilities And Stockholders Equity | $486.8K | $149.1K | $31.6K | $42.3M | $39.2M | $40.2M | $497.1K | ||||
| Common Stock Value | $211.1K | $149.2K | $1.7K | $7.7K | $996.2K | $530.0K | $57.4K | ||||
| Assets Current | $357.9K | $17.7K | $452.00 | $36.7M | $34.1M | $33.9M | $296.6K | ||||
| Liabilities Current | $1.4M | $910.1K | $35.6M | $31.5M | $32.0M | $2.6M | |||||
| Property Plant And Equipment Net | $89.5K | $131.4K | $519.3K | $569.0K | $684.8K | $0.00 | |||||
| Cash And Cash Equivalents Period Increase Decrease | $15.2K | -$66.00 | $3.5M | $1.6M | $2.8M | $7.2K | |||||
| Intangible Assets Net Excluding Goodwill | $39.3K | $0.00 | $31.2K | $3.6M | $3.3M | $3.5M | |||||
| Accounts Receivable Net Current | $24.9M | $24.9M | $26.6M | ||||||||
| Inventory Net | $18.5K | $220.4K | $125.8K | ||||||||
| Amortization Of Debt Discount Premium | $6.5K | $19.9K | $57.1K | $26.0K | $162.4K | $166.5K | |||||
| Other Assets Current | $837.7K | $817.0K | $1.2M | ||||||||
| Liabilities Noncurrent | $47.1K | $45.7K | $218.6K | ||||||||
| Deferred Tax Assets Net Noncurrent | $1.3M | $1.1M | $2.2M | ||||||||
| Deferred Tax Assets Net Current | $282.6K | $718.8K | $317.9K | ||||||||
| Assets Noncurrent | $5.5M | $5.1M | $6.3M | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$864.8K | -$1.1M | -$244.3K | ||||||||
| Accounts Payable Trade Current | $7.0M | $3.1M | $6.6M | ||||||||
| Development Of Intangible Assets | -$518.2K | -$753.5K | -$747.6K | -$706.5K | |||||||
| Preferred Stock Value | $6.0K | $6.2K | $45.00 | $0.00 | |||||||
| Convertible Notes Payable Current | $514.4K | $306.1K | $321.2K | $413.0K | |||||||
| Cash Reserve | $1.3M | $878.7K | $2.7M | $703.0K | |||||||
| Goodwill | $71.2K | $69.1K | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $14.0K | $192.8K | |||||||||
| Trade Receivables Held For Sale Reconciliation To Cash Flow Additions To Held For Sale | $782.6K | -$3.6M | -$7.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$2.0M | -$2.0M | -$1.9M | -$1.7M | -$549.7K | -$1.2M | -$1.1M | -$910.0K | -$1.1M | -$931.3K | -$906.5K | $1.7M | $2.3M | -$466.7K | $3.1M | -$140.6K | $13.4K | $3.8M | $3.8M | $4.4M | $4.6M | $5.8M | $7.3M | $7.1M | -$589.0K | -$390.3K | -$858.7K | -$731.1K | -$649.2K | -$239.6K | -$2.1M | -$2.1M | ||||||||
| Cash And Cash Equivalents At Carrying Value | $884.00 | $15.6K | $9.8K | $32.00 | $77.00 | $452.00 | $123.00 | $28.00 | $5.1M | $7.0M | $10.7M | $7.5M | $6.9M | $7.1M | $7.1M | $5.6M | $5.4M | $8.9K | $24.0K | $35.8K | $33.2K | $191.4K | $224.9K | $30.1K | $28.5K | |||||||||||||||
| Assets | $286.0K | $245.1K | $349.6K | $222.9K | $1.3M | $362.8K | $2.2M | $2.8M | $302.7K | $3.5M | $244.6K | $36.4K | $39.2M | $36.8M | $33.4M | $29.1M | $33.0M | $34.3M | $33.5M | $41.2M | $40.6M | $363.4K | $45.4M | $40.9M | $217.2K | $240.7K | $497.1K | |||||||||||||
| Liabilities | $2.3M | $2.2M | $2.3M | $2.0M | $1.8M | $1.5M | $769.4K | $636.6K | $385.2K | $23.0K | $35.4M | $36.1M | $33.0M | $28.9M | $24.5M | $27.7M | $28.6M | $26.2M | $33.8M | $32.7M | $952.4K | $37.1M | $32.5M | $948.3K | $889.9K | $2.6M | ||||||||||||||
| Retained Earnings Accumulated Deficit | -$2.3M | -$2.2M | -$2.1M | -$1.8M | -$1.7M | $1.1M | -$9.8M | -$8.0M | -$773.8K | -$3.8M | -$279.0K | -$125.0K | -$9.9M | -$9.3M | -$8.6M | -$8.4M | -$8.1M | -$7.9M | -$7.6M | -$7.6M | -$10.9M | -$10.7M | -$10.0M | -$9.8M | -$9.7M | -$9.0M | ||||||||||||||
| Liabilities And Stockholders Equity | $286.0K | $245.1K | $349.6K | $222.9K | $1.3M | $362.8K | $2.2M | $2.8M | $302.7K | $3.5M | $244.6K | $36.4K | $39.2M | $36.8M | $33.4M | $29.1M | $33.0M | $34.3M | $33.5M | $40.9M | $363.4K | $204.3K | $265.9K | $217.2K | $240.7K | $497.1K | ||||||||||||||
| Common Stock Value | $211.1K | $211.1K | $211.1K | $211.1K | $211.1K | $211.1K | $165.7K | $165.9K | $10.7K | $126.3K | $5.8K | $5.8K | $8.8K | $8.8K | $7.7K | $7.7K | $7.7K | $7.7K | $7.7K | $9.8K | $206.1K | $207.7K | $137.0K | $133.3K | $53.3K | $57.4K | ||||||||||||||
| Assets Current | $98.0K | $63.6K | $171.3K | $28.6K | $1.1M | $205.6K | $1.9M | $2.6M | $276.1K | $3.3M | $214.8K | $5.0K | $35.2M | $32.8M | $29.0M | $24.7M | $28.4M | $29.2M | $28.1M | $35.9M | $123.4K | $13.0K | $66.1K | $8.9K | $24.0K | $296.6K | ||||||||||||||
| Liabilities Current | $2.3M | $2.2M | $2.3M | $2.0M | $1.8M | $1.5M | $470.2K | $471.6K | $769.4K | $392.1K | $385.2K | $23.0K | $16.8M | $18.5M | $16.0M | $10.4M | $24.4M | $27.7M | $28.5M | $26.1M | $33.7M | $952.4K | $594.6K | $1.1M | $948.3K | $889.9K | ||||||||||||||
| Property Plant And Equipment Net | $34.8K | $38.2K | $41.9K | $66.4K | $67.1K | $76.2K | $261.2K | $189.6K | $126.6K | $251.5K | $267.5K | $282.4K | $326.9K | $349.2K | $380.3K | $442.7K | $489.8K | $502.7K | $9.8K | $10.8K | $11.8K | $12.7K | $13.7K | $0.00 | $0.00 | |||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$14.8K | -$375.00 | -$870.4K | -$3.7M | -$105.3K | $104.3K | -$11.9K | $155.8K | $189.2K | $1.6K | ||||||||||||||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $26.7K | $28.2K | $29.8K | $31.4K | $2.8M | $2.6M | $2.9M | $2.9M | $3.2M | $3.4M | $3.5M | $3.3M | ||||||||||||||||||||||||||||
| Accounts Receivable Net Current | $45.3K | $51.3K | $17.5K | $25.7M | $27.1M | $24.4M | $19.7M | $18.5M | $19.1M | $21.1M | $19.2M | $26.8M | ||||||||||||||||||||||||||||
| Inventory Net | $231.0K | $44.4K | $68.9K | $117.9K | $109.8K | $157.1K | $246.9K | $17.9K | $20.8K | $210.9K | $206.2K | |||||||||||||||||||||||||||||
| Amortization Of Debt Discount Premium | $0.00 | $0.00 | $0.00 | $0.00 | $808.00 | $5.7K | $0.00 | $0.00 | $30.8K | $10.7K | $68.2K | $17.1K | $127.4K | |||||||||||||||||||||||||||
| Other Assets Current | $1.1M | $911.8K | $782.1K | $779.9K | $577.3K | $989.3K | $888.1K | $862.0K | $1.5M | |||||||||||||||||||||||||||||||
| Liabilities Noncurrent | $18.6M | $17.7M | $16.9M | $18.5M | $38.2K | $41.0K | $43.8K | $46.1K | $44.7K | |||||||||||||||||||||||||||||||
| Deferred Tax Assets Net Noncurrent | $784.6K | $765.2K | $790.3K | $885.4K | $939.8K | $1.0M | $1.2M | $1.4M | $1.1M | |||||||||||||||||||||||||||||||
| Deferred Tax Assets Net Current | $229.7K | $219.2K | $210.3K | $230.4K | $229.0K | $246.1K | $282.6K | $276.6K | $268.4K | |||||||||||||||||||||||||||||||
| Assets Noncurrent | $4.0M | $4.0M | $3.9M | $4.4M | $4.4M | $4.6M | $5.1M | $5.4M | $5.0M | |||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.2M | -$2.4M | -$2.5M | -$2.1M | -$2.2M | -$1.8M | -$1.4M | -$1.0M | -$1.2M | |||||||||||||||||||||||||||||||
| Accounts Payable Trade Current | $3.1M | $2.2M | $2.0M | $3.1M | $2.7M | $5.3M | $3.9M | $4.2M | $5.3M | |||||||||||||||||||||||||||||||
| Development Of Intangible Assets | -$94.9K | -$183.6K | -$167.6K | |||||||||||||||||||||||||||||||||||||
| Preferred Stock Value | $5.8K | $5.8K | $5.8K | $7.1K | $7.1K | $6.1K | $21.00 | $21.00 | $45.00 | $45.00 | $50.00 | $50.00 | $50.00 | $79.9K | $0.00 | $0.00 | ||||||||||||||||||||||||
| Convertible Notes Payable Current | $911.3K | $911.3K | $911.3K | $681.3K | $580.8K | $520.8K | $350.0K | $350.0K | $250.0K | $889.5K | $497.2K | $942.2K | $760.6K | $736.9K | $413.0K | |||||||||||||||||||||||||
| Cash Reserve | $1.2M | $1.1M | $1.3M | $820.2K | $2.6M | |||||||||||||||||||||||||||||||||||
| Goodwill | $57.9K | $55.2K | $53.0K | $58.1K | $57.7K | $62.0K | $66.2K | $69.7K | $67.7K | |||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $504.00 | $62.6K | $168.8K | $22.1K | $8.4K | $21.6K | $79.5K | $167.7K | $216.8K | $71.9K | ||||||||||||||||||||||||||||||
| Trade Receivables Held For Sale Reconciliation To Cash Flow Additions To Held For Sale |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $325.2K | $143.1K | $126.2K | $730.3K | $807.7K | ||||
| Net Cash Provided By Used In Operating Activities | -$199.8K | -$29.5K | -$175.5K | -$96.3K | -$10.1K | $4.8M | -$2.9M | -$4.0M | -$1.1M |
| Net Cash Provided By Used In Financing Activities | $142.0K | $201.8K | $20.7K | $364.8K | $10.0K | -$651.4K | $6.1M | $7.8M | $1.1M |
| Net Cash Provided By Used In Investing Activities | -$87.8K | -$18.6K | -$24.1K | -$253.3K | -$572.6K | -$880.8K | -$824.7K | -$791.0K | $0.00 |
| Depreciation Depletion And Amortization | $729.5K | $738.1K | $697.0K | $594.0K | $178.9K | ||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $24.1K | $54.5K | $127.3K | $32.1K | $84.5K | |||
| Increase Decrease In Inventories | $155.1K | -$203.7K | $120.6K | $3.4K | |||||
| Increase Decrease In Undisbursed Loan Funds | -$18.1M | $1.2M | $3.9M | $7.8M | |||||
| Increase Decrease In Other Operating Assets | $100.6K | -$45.0K | -$324.9K | -$862.5K | |||||
| Increase Decrease In Accounts Payable Trade | -$3.0M | $3.2M | -$769.1K | $3.7M | |||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | -$1.9M | $307.6K | -$827.4K | -$164.0K | |||||
| Increase Decrease In Prepaid Expense | -$183.8K | $186.5K | -$2.8K | $23.3K | -$64.5K | -$1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q2 2012 | Q3 2011 | Q2 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $1.1M | $2.6M | $109.6K | $0.00 | $489.3K | $293.0K | $406.3K | $25.2K | $396.8K | $279.7K | $37.9K | $403.5K | $289.1K | $67.4K | $178.8K | $232.0K | |||||||
| Net Cash Provided By Used In Operating Activities | -$74.9K | -$71.9K | -$15.9K | -$6.1K | -$7.7M | -$830.2K | -$778.4K | -$228.5K | -$101.7K | -$84.3K | -$55.8K | -$233.4K | |||||||||||
| Net Cash Provided By Used In Financing Activities | $230.0K | $0.00 | $1.1K | $9.0K | $7.7M | -$2.1M | $820.5K | $390.0K | $81.8K | $245.0K | $245.0K | $235.0K | |||||||||||
| Net Cash Provided By Used In Investing Activities | -$8.4K | -$16.4K | -$3.3K | -$106.2K | -$185.1K | -$216.9K | -$57.2K | $8.1K | -$4.9K | $0.00 | $0.00 | ||||||||||||
| Depreciation Depletion And Amortization | $160.6K | $197.9K | $177.4K | $8.5K | $8.5K | $110.2K | $60.5K | $35.2K | |||||||||||||||
| Payments To Acquire Property Plant And Equipment | $11.3K | $1.5K | $49.3K | ||||||||||||||||||||
| Increase Decrease In Inventories | -$34.8K | $3.9K | $10.3K | ||||||||||||||||||||
| Increase Decrease In Undisbursed Loan Funds | $7.4M | -$2.6M | $836.1K | ||||||||||||||||||||
| Increase Decrease In Other Operating Assets | $67.5K | $116.0K | $150.4K | ||||||||||||||||||||
| Increase Decrease In Accounts Payable Trade | -$975.3K | -$2.8M | -$348.0K | ||||||||||||||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | -$698.6K | -$589.9K | $134.6K | ||||||||||||||||||||
| Increase Decrease In Prepaid Expense | -$4.0K | -$2.8K | $1.8K | $5.0K | $6.1K | $0.00 | $35.2K | -$17.6K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | -$0.11 | -$0.01 | -$0.09 | -$0.00 | $0.05 | -$0.06 | |
| Weighted Average Number Of Diluted Shares Outstanding | 211.1M | 141.2M | 7.7M | 9.4M | 5.3M | 5.3M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 172.9M | 94.8M | 1.7M | 7.7M | 10.0M | 5.3M | 57.4M | ||
| Common Stock Shares Issued | 211.1M | 149.2M | 1.7M | 7.7M | 10.0M | 5.3M | 57.4M | ||
| Common Stock Shares Authorized | 500.0M | 500.0M | 12.0M | 50.0M | 50.0M | 250.0M | 250.0M | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0K | 1.0M | 1.0M | 10.0M | 10.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||
| Weighted Average Number Of Shares Outstanding Basic | 7.7M | 9.4M | 5.3M | 5.3M | |||||
| Earnings Per Share Basic | $0.00 | $0.05 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.02 | -$0.01 | $0.00 | -$0.01 | $0.00 | -$0.03 | -$0.01 | $0.00 | -$0.04 | -$0.02 | -$0.04 | -$0.04 | -$0.02 | -$0.03 | -$0.10 | $0.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Weighted Average Number Of Diluted Shares Outstanding | 211.1M | 211.1M | 211.1M | 211.1M | 211.1M | 211.1M | 8.8M | 8.8M | 7.9M | 7.7M | 7.7M | 7.7M | 9.1M | 10.2M | 10.4M | 5.3M | 5.3M | 77.6M | 134.9M | 70.0M | 52.7M | 48.7M | ||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.10 | $0.10 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Common Stock Shares Outstanding | 211.1M | 211.1M | 211.1M | 172.9M | 172.9M | 172.9M | 165.7M | 165.9M | 10.7M | 126.3M | 5.8M | 5.8M | 8.8M | 8.8M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 9.8M | 2.1M | 207.7M | 137.0M | 133.3M | 53.3M | 9.8M | ||||||
| Common Stock Shares Issued | 211.1M | 211.1M | 211.1M | 211.1M | 211.1M | 211.1M | 165.7M | 165.9M | 10.7M | 126.3M | 5.8M | 5.8M | 8.8M | 8.8M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 9.8M | 2.1M | 207.7M | 137.0M | 133.3M | 53.3M | 70.0M | ||||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 12.0M | 500.0M | 12.0M | 12.0M | 12.0M | 12.0M | 12.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 500.0M | 500.0M | 250.0M | 250.0M | 250.0M | 150.0M | ||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0K | 10.0M | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 1.0M | 1.0M | 1.0M | 10.0M | 1.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 8.8M | 8.8M | 7.9M | 7.7M | 7.7M | 7.7M | 9.1M | 10.2M | 10.4M | 5.3M | 5.3M | 77.6M | 53.0M | 70.0M | 52.7M | 48.7M | ||||||||||||||||
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $699.7K | $673.9K | $140.2K | $15.0M | $14.5M | $14.6M | $6.9M | ||
| Interest Paid | $1.8M | $1.7M | $1.9M | $1.7M | $3.6K | ||||
| Utilities Operating Expense Depreciation And Amortization | $56.1K | $61.7K | $75.8K | $129.2K | |||||
| Occupancy Costs | $227.0K | $250.7K | $254.1K | $254.1K | |||||
| Interest Income Other | $144.0K | $109.0K | $114.3K | -$109.9K | |||||
| Baddebtexpenses | $791.9K | $393.8K | $78.0K | ||||||
| Due To Officers Or Stockholders Noncurrent | $47.1K | $45.7K | $218.6K | ||||||
| Wholesale Loan Facility | $6.1M | $27.7M | $25.7M | $24.7M | |||||
| Finance Costs | -$16.8K | -$28.6K | |||||||
| Capital Reserve | $590.9K | -$1.9M | $2.4M | ||||||
| Other Expenses | $378.0K | $378.0K | $378.0K | $4.6K | $7.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q3 2011 | Q2 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $58.8K | $990.00 | $990.00 | $818.6K | $1.9M | $699.6K | $11.3M | $10.2M | $296.3K | $6.8M | $132.5K | $132.5K | $15.8M | $15.6M | $15.2M | $15.1M | $15.1M | $15.1M | $16.0M | $15.9M | $10.1M | $10.1M | $9.0M | $9.0M | $8.9M | $6.9M | |||||||
| Interest Paid | $538.4K | $457.8K | -$466.4K | $38.7K | $34.1K | $2.7K | $2.7K | $1.8K | |||||||||||||||||||||||||
| Utilities Operating Expense Depreciation And Amortization | $7.6K | $7.7K | $8.1K | $13.1K | $15.9K | $18.4K | $13.0K | $16.8K | $20.1K | $23.7K | $18.9K | ||||||||||||||||||||||
| Occupancy Costs | $52.1K | $60.5K | $66.7K | $52.9K | $53.0K | $62.5K | $56.9K | $70.1K | $59.1K | $70.6K | $64.9K | ||||||||||||||||||||||
| Interest Income Other | $45.2K | $45.1K | $37.6K | $20.3K | $23.9K | $30.0K | $27.4K | $26.4K | $26.8K | $28.7K | $23.9K | ||||||||||||||||||||||
| Baddebtexpenses | $68.0K | $291.6K | $30.3K | $221.0K | $46.3K | $61.7K | |||||||||||||||||||||||||||
| Due To Officers Or Stockholders Noncurrent | $38.3K | $36.5K | $35.0K | $38.4K | $38.2K | $41.0K | $43.8K | $46.1K | $44.7K | ||||||||||||||||||||||||
| Wholesale Loan Facility | $20.5M | $21.3M | $23.3M | $21.1M | $25.6M | ||||||||||||||||||||||||||||
| Finance Costs | -$3.00 | $284.00 | -$1.00 | ||||||||||||||||||||||||||||||
| Capital Reserve | $501.6K | -$15.5K | |||||||||||||||||||||||||||||||
| Other Expenses | $70.7K | $30.0K | $0.00 | $94.5K | $94.5K | $99.5K | $116.2K | $94.5K | $6.9K | $307.00 | $3.3K |
Most recent annual filing with the SEC: April 7, 2025
Data sourced from SEC EDGAR public filings as of August 7, 2026.